Runner's High Has an Endocannabinoid Signature in Humans. Dogs Show It Too. ↗
High-intensity running raised blood endocannabinoids in humans and dogs, not in ferrets and not during walking.
Explore published research on exercise, including study methods and limitations.
High-intensity running raised blood endocannabinoids in humans and dogs, not in ferrets and not during walking.
Review found THC is generally performance-impairing despite WADA prohibition, with impaired reaction time, coordination, and strength, contrasting with caffeine's clear ergogenic effects.
Cannabis-dependent veterans with moderate/high physical activity were less likely to relapse during the first week of quitting, especially in the first four days.
Systematic review found that exercise, massage, acupuncture, several medication classes, and lifestyle factors all upregulate the endocannabinoid system, relevant to conditions like migraine and fibromyalgia.
Commentary found almost no research on the cannabis-exercise relationship, despite widespread beliefs about both motivational impairment and performance enhancement.
Systematic review of 15 studies finding THC does not improve aerobic performance or strength, inhibits exercise-induced asthma, and triggered angina at lower workloads in all cardiac-vulnerable subjects.
Review mapping how blood endocannabinoid levels shift with exercise, sleep, stress, pain, and metabolism — showing why cannabis affects so many different systems.
Systematic review found only three trials on marijuana and athletic performance, with low-quality evidence for both potential benefits (bronchodilation) and harms (decreased work capacity).
Review found no evidence cannabis enhances athletic performance, limited evidence of serious harms in athletes, and promising but unconfirmed potential for pain management and concussion symptom relief.
Study of 79 young adults found aerobic fitness moderated cognitive deficits associated with cannabis use, with fitter users performing better after 3 weeks of abstinence.
Systematic review found only four relevant studies and no evidence that chronic cannabis use significantly affects VO2max or physical work capacity.
Review found preclinical evidence for CBD benefits relevant to athletes (pain, inflammation, anxiety), but no studies have directly tested CBD in athletic populations.
Treadmill exercise reversed memory deficits from brain inflammation in rats by modulating CB1/CB2 receptors and inflammatory enzymes in the hippocampus.
A survey of 1,161 athletes found that attitudes about cannabis mediated the relationship between knowledge and use, with liberal-attitude athletes showing more knowledge and higher current use.
Cannabis and THC show no benefits for athletic performance and may impair cardiovascular function during exercise. CBD shows more promise for recovery, potentially aiding sleep, pain management, and mild traumatic brain injury recovery.
A systematic review of 18 publications found cannabis before exercise reduces endurance, increases heart rate and oxygen demand, and impairs balance. Cannabis is ergolytic (performance-reducing), not performance-enhancing.
Mouse study found that acute THC did not affect running preference, performance, or motivation, even though CB1 receptors were necessary for running drive, contradicting popular beliefs about cannabis enhancing exercise.
A randomized trial found daily moderate-intensity cycling during inpatient cannabis withdrawal improved objective sleep duration and efficiency compared to stretching, though participants did not perceive the difference.
Study of 74 young people found cannabis affected brain volume differently by sex (females had more, males had less), while higher aerobic fitness was linked to greater brain volume overall.
Meta-analysis confirmed that acute exercise consistently increases endocannabinoid levels, potentially explaining mood and pain benefits of physical activity.
CBD and THC do not boost athletic performance. CBD's anti-inflammatory potential remains untested in sport. Some CBD products may trigger positive drug tests due to THC contamination.
Pilot RCT of 9 trained runners found 300 mg CBD appeared to increase oxygen consumption, exercise pleasure, and VO2max without affecting endurance performance or heart rate.
Perspective argues cannabis should be removed from the WADA prohibited list because it does not enhance performance, its health risks are overestimated, and the ban relies on subjective moral criteria.
Controlled crossover study found THC-containing cannabis impaired 20-minute cycling time trial performance whether smoked or vaped, while CBD-dominant cannabis had no effect on exercise output.
A placebo-controlled trial found 150mg CBD had no effect on mood, enjoyment, pain, or performance during a 10km run.
Large national survey finds cannabis users are 24% more likely to be physically active, with the strongest association in states with legal recreational cannabis.
300 mg CBD increased feelings of calm and relaxation before a 2-mile run but had no effect on running speed, heart rate, or other performance measures in 12 runners.
Cancer patients had lower baseline endocannabinoid levels, but 30 minutes of moderate exercise boosted endocannabinoids in both cancer patients and healthy controls — along with increased happiness.
Women with fibromyalgia had elevated plasma anandamide that correlated with higher pain and lower fitness, while PAG-thalamus brain connectivity was linked to physical activity.
Crossover RCT found 60 mg/day CBD for 7 days blunted exercise-induced liver enzyme elevations in athletes without hepatotoxicity, with medium-to-large effect sizes.
ABCD study found light physical activity (measured by Fitbit) reduced odds of substance use initiation by 26% in adolescents, while moderate and vigorous activity had no significant effect.
A survey of 80 elite Canadian athletes found 38% had used CBD, with most reporting benefits for sleep (93%) and relaxation (90%). Anti-doping violation concerns were the top barrier to use.
A 28-day daily diary study found cannabis use days were associated with slightly more physical activity, more drinking, and more cigarette smoking.
Genetic study finds leisure screen time increases cannabis use disorder risk by 43%, with smoking initiation mediating over half the effect. Sedentary desk work was protective.
Study of 358,391 young people across 45 countries finds cannabis use has no significant link to reduced physical activity, while tobacco use consistently does.
Review found cannabis and exercise share overlapping effects on brain health through inflammation, blood flow, and neuroplasticity pathways, with potential for both beneficial and harmful interactions.
Rigorous RCT found 12 weeks of high-intensity exercise did not improve brain structure or mental health in cannabis use disorder, though 80% of participants completed the program and exercise reduced cravings.
Study of 80 adults with depression found higher physical fitness associated with lower resting plasma endocannabinoid levels, suggesting a more regulated system.
Rigorous crossover trial found CBD at 50 mg and 300 mg did not improve or impair running performance, mood, or perceived exertion in trained athletes.
Six weeks of HIIT reduced CB1 receptors across brain regions in rats, with sex differences in baseline and cerebellar response.
A study of 27 cancer survivors found CBD (up to 300 mg/day) improved nerve damage symptoms, and adding exercise further enhanced pain relief, mobility, and quality of life over 4 months.
Preclinical study showing exercise improves Parkinson's motor function through CB1 receptor modulation in the striatum, linking endocannabinoid signaling to exercise's therapeutic effects.
Rat study shows CBD and aerobic exercise synergistically protect insulin-producing beta cells in obesity through the PI3K/AKT/PDX1 pathway, with CBD driving functional improvement.
NHANES analysis of 4,400+ adults found recreational exercise linked to less cannabis use, while sedentary behavior and work-related activity linked to more — suggesting the type of physical activity matters.
A 10-week trial found that daily broad-spectrum CBD use produced WADA-prohibited cannabinoids (CBG, CBDV) in urine, with exercise significantly increasing concentrations — posing real anti-doping risks for athletes.
Survey of 139 Ghanaian pro footballers found 44.6% used substances, with caffeine dominant and cannabis use under 3%.
Cannabis made running more enjoyable (90.5%), less painful (69%), and more motivating (57%) — without improving performance. CBD worked better than THC for exercise enjoyment.